FDA & Prescription Drugs
Eye Damage caused by SJS & TEN
Many patients with the rare skin conditions Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) also experience involvement with the eyes, according to a study published in the…
FDA & Prescription Drugs
FDA & Prescription Drugs
Human Embryonic Stem Cell Therapy Cleared by FDA
Recently, FDA has announced the “first-ever human trial of a medical treatment, derived from embryonic stem cells” is now allowed. WCSH6 reported that the company is planning on…
@large.jpg)
FDA & Prescription Drugs
Dilantin Related Stevens Johnson Syndrome-Those Affected Continue To Suffer
The attorneys at Childers and Schlueter, LLP continue to review and investigate Dilantin and phenytoin related cases of Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TENS). The…
FDA & Prescription Drugs
2009 Wise Tips from Atlanta Journal Constitution
The Atlanta Journal Constitution wrote an article yesterday on tips for 2009 or any year for the purpose of watching out for your safety and pocketbook. I thought they were very good tips for anyone…
FDA & Prescription Drugs
False Sense of Security
The Atlanta Journal-Constitution reported last Sunday that an analysis of federal data found taxpayers have paid out around 200 million dollars since 2004 for medications that have never been…
FDA & Prescription Drugs
FDA Study Finds Private-Sector Consumer Medication Information not Consistently Useful
FDA released the results of a study today finding printed consumer medication information voluntarily provided by retail pharmacies with new prescriptions does not provide user friendly, easy to…
FDA & Prescription Drugs
The Line has been Drawn—Serevent & Foradil Should no Longer be Used to Treat Asthma
The FDA panel, with outside advisers, made their decision and decided that two of the four asthma drugs should not longer be used in the treatment of asthma as discussed in my previous post: FDA to…
FDA & Prescription Drugs
FDA to decide whether to Leave Four Medications Used for Asthma on the Market
Today FDA is seeking the advice of a large panel of medical and scientific advisers concerning whether four medications used for asthma patients should remain on the market. NY times reports that…
FDA & Prescription Drugs
Use of Avandia Doubles Women’s Fracture Risk
USA Today reports that researchers at Wake Forest University of Medicine reviewed 10 previous drug trials and found for every 20 women in their 70s with type 2 diabetes who took the brand name…
FDA & Prescription Drugs
FDA Investigation of Potential Risk from Phenytoin & Fosphenytoin
FDA released an alert yesterday regarding investigation of new data about a potential risk of serious skin reaction from phenytoin therapy in Asian patients positive for a particular human leukocyte…
FDA & Prescription Drugs
Updates on Bisphosphonate (Fosamax)
In October of 2007, FDA began reviewing safety data that raised concerns about the potential increased risk for atrial fibrillation in patients who were treated with a bisphosphonate drug. The New…
FDA & Prescription Drugs
Contaminated Heparin seized by FDA
After asking a Cincinnati based manufacturer of medical products to recall contaminated heparin and the manufacturer not answering, FDA seized the contaminated heparin. This past Thursday, FDA sent…